FRONTIER · GLOBAL
AI agent autonomously selects and administers gene therapy in live animal trial
A biotech startup deployed an autonomous AI agent that chose a gene therapy candidate and successfully injected it into a living mouse without human intervention. The agent interpreted lab data, reasoned about treatment options, and executed the procedure.
WHY IT MATTERS
Demonstrates AI agents can operate in high-stakes, regulated environments with real consequences. For BFSI, this signals that autonomous decision-making in trading, lending, and compliance is moving from simulation to live markets—raising liability and regulatory questions.
Source: Wired · 2026-10-31